SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company
· SANUWAVE Health Inc. (OTCQB:SNWV) has entered into a definitive merger agreement with SEP Acquisition Corp. (NASDAQ:SEPA). Upon closing, the combined company is expected to trade on the Nasdaq Capital Market under the symbol "SNWV". · The combined company expects to receive approximately $13.0 million of gross proceeds at closing, including $12.0 million from non-redeeming holders of SEPA's Class A common stock and other PIPE investors, and $1.0 million from the SPAC sponsor converting a loan into equity on the same terms as the PIPE. Approximately $8.5 million of capital has already been committed. · This funding is expected to be anchored by investors affili
